Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Arezzo
Clinical trial register · Italy

Clinical Trials in Arezzo, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 2846 Bologna 1303 Roma 1272 Naples 983 Rome 968
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca9 Merck Sharp & Dohme LLC8 Janssen Research & Development, LLC6 University Hospital of Ferrara2 Pfizer2
Site location
Milan2846 Bologna1303 Roma1272 Naples983 Rome968
All 489 locations
Target enrolment
to

Trials with a site in Arezzo

59 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Heart Care Foundation
Phase 3
600
Acquaviva delle Fonti, Altamura, Arezzo, Avellino, Bari, Casale Monferrato, Caserta, Catania
2026-09
Recruiting
Chiesi Italia
Observational
75
Arezzo, Bari, Bologna, Caserta, Monza, Naples, Palermo
2026-06-15
Recruiting
University Hospital of Ferrara
Not applicable
1,612
Andria, Arezzo, Bologna, Ferrara, Grosseto, L’Aquila, Mirano, Ravenna
2026-05-25
Recruiting
Merck Sharp & Dohme LLC
Phase 3
590
Rozzano, Orbassano, Verona, Arezzo, Genova, Milan, Roma
2026-04-23
Not yet open
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 2
270
Arezzo, Aviano, Bologna, Brescia, Catania, Cuneo, Florence, Genova
2026-01-31
Recruiting
Centro di Riferimento Oncologico - Aviano
Observational
1,000,000
Altamura, Ancona, Arezzo, Belluno, Florence, Milan, Modena, Monza
2025-10-08
Recruiting
AstraZeneca
Phase 3
700
Arezzo, Bari, Bergamo, Chieti, Genoa, Milan, Naples, Palermo
2025-08-06
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,440
Milan, Rozzano, Rome, Siena, Arezzo, Bergamo, Foggia, Terni
2025-05-13
Not yet open
Fondazione Andrea Cesalpino Arezzo ONLUS
Phase 4
530
Arezzo
2025-04-01
Active, closed
Celgene
Phase 3
960
Milan, Orbassano, Rome, Padova, Arezzo, Foggia, Naples, Terni
2025-03-13
Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
NCT06833073Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ
DrugIntismeran autogene
Merck Sharp & Dohme LLC
Phase 2
308
Milan, Rome, Arezzo, Roma
2025-03-11
Recruiting
Biotronik AG
Observational
200
Abano Terme, Arezzo, Siena
2024-12-19
Recruiting
Meyer Children's Hospital IRCCS
Observational
138
Arezzo, Bagno a Ripoli, Florence, Pisa, Pistoia, Prato, Siena
2024-12-04
Active, closed
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy
NCT06481891Obstructive Cardiomyopathy, Hypertrophic, Non-obstructive Hypertrophic Cardiomyopathy
DrugSotagliflozin
Lexicon Pharmaceuticals
Phase 3
500
Arezzo, Brescia, Naples
2024-09-24
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
31
Arezzo, Bolzano, Catania, Pavia, Piacenza
2024-06-30
Recruiting
University Hospital, Antwerp
Phase 3
174
Milan, Arezzo, Bergamo, Brescia, Florence, Lecco, Pavia, Pisa
2024-05-24
Recruiting
Janssen Research & Development, LLC
Phase 3
641
Arezzo, Bergamo, Brescia, Milan, Roma, Rozzano, Torino
2024-04-18
Active, closed
Janssen Research & Development, LLC
Phase 3
272
Arezzo, Milan, Province of Macerata, Ravenna, Roma, Rozzano, Torino
2024-04-09
Recruiting
ASST Ovest Milanese
Not applicable
140
Monfalcone, Abbiategrasso, Abano Terme, Arezzo, Forlì, Lucca, Pisa
2024-03-21
Recruiting
medac GmbH
Phase 3
277
Arezzo, Ferrara, Florence, Naples, Parma, Pisa
2024-02-27
Recruiting
Population Health Research Institute
Not applicable
5,100
Arezzo, Bologna, Ferrara, Grosseto, Reggio Emilia, Rome
2023-06-22
Active, closed
Azienda Usl di Bologna
Not applicable
657
Bologna, Arezzo, Asti, Biella, Ferrara, Forlì, Grosseto, Mirano
2023-05-01
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Arezzo, Aversa, Bergamo, Bologna, Caserta, Catania, Catanzaro, Ferrara
2023-04-11
Active, closed
Exelixis
Phase 3
317
Rozzano, Candiolo, Arezzo, Bari, Brescia, Meldola, Milan, Naples
2023-01-01
Recruiting
ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing
NCT06324682Arrhythmias, Cardiac, Atrioventricular Block, Reduced Systolic Function, Atrial Fibrillation
University Hospital of Ferrara
Observational
8,400
Ferrara, Arezzo, Bologna, Carpi, Cento, Cesena, Empoli, Fidenza
2023-01-01
Recruiting
AstraZeneca
Phase 3
3,527
Arezzo, Brescia, Naples, Roma, Rozzano, Torino
2022-12-13
Active, closed
Almirall, S.A.
Phase 4
447
Arezzo, Brescia, Genova, Modena, Naples, Reggio Emilia, Roma, Rozzano
2022-10-24
Recruiting
Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial)
NCT05601700Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of Ovary
DrugLetrozole
Ente Ospedaliero Ospedali Galliera
Phase 3
132
Arezzo, Ponderano, Belluno, Brescia, Como, Meldola, Ferrara, Genova
2022-09-22
By invitation
AstraZeneca
Phase 3
214
Arezzo, Bari, Catania, Meldola, Milan, Modena, Padova, Pisa
2022-04-19
Active, closed
AstraZeneca
Phase 3
760
Arezzo, Florence, Milan, Roma, Rozzano, Tricase
2022-03-28
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,800
Bari, Meldola, Rome, Milan, Orbassano, Florence, Arezzo, Bologna
2022-03-15
Recruiting
Mario Negri Institute for Pharmacological Research
Observational
2,500
Alessandria, Arezzo, Baggiovara, Bergamo, Bologna, Brescia, Cagliari, Correggio
2022-01-03
Active, closed
AstraZeneca
Phase 3
148
Arezzo, Avellino, Bari, Bologna, Florence, Meldola, Milan, Naples
2021-10-28
Active, closed
Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
NCT04988386Amyloid Cardiomyopathy, Transthyretin-Related
DrugAcoramidis
Eidos Therapeutics, a BridgeBio company
Phase 3
389
Arezzo, Florence, Pisa, Pavia
2021-10-27
Recruiting
L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.
Not applicable
78
Arezzo, Florence, Genova, Milan, Palermo, Perugia, Pistoia
2021-09-14
Recruiting
Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease
NCT04912323Peripheral Arterial Disease, Atherosclerotic Lesion, Lower Extremity Ischemia, Lower Extremity Claudication
R3 Vascular Inc.
Not applicable
30
Arezzo, Cotignola, Milan
2021-08-17
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Arezzo, Bologna, Caserta, Catania, Catanzaro, Cona, Florence, Messina
2021-08-14
Active, closed
Pfizer
Phase 3
599
Bologna, Cremona, Meldola, San Giovanni Rotondo, Naples, Aviano, Trento, Arezzo
2021-05-12
Active, closed
Hoffmann-La Roche
Phase 3
761
Naples, Bologna, Meldola, Rome, Genoa, Milan, Orbassano, Arezzo
2021-05-03
Active, closed
Merck Sharp & Dohme LLC
Phase 3
747
Meldola, Rozzano, Orbassano, Arezzo, Bari, Milan, Pavia, Roma
2021-02-25
Active, closed
Janssen Research & Development, LLC
Phase 3
518
Arezzo, Candiolo, Carpi, Catania, Foggia, Genova, Lugo, Milan
2020-12-07
Active, closed
Janssen Research & Development, LLC
Phase 3
696
Arezzo, Candiolo, Cremona, Lecce, Meldola, Milan, Naples, Orbassano
2020-09-23
Active, closed
Merck Sharp & Dohme LLC
Phase 3
755
Verona, Arezzo, Bari, Bologna, Milan, Modena, Padova, Pavia
2020-02-27
Active, closed
Pfizer
Phase 3
1,068
Misterobianco (CT), Cremona, Rozzano, Turin, Reggio Emilia, Arezzo, Bari, Genova
2019-12-30
Active, closed
Merck Sharp & Dohme LLC
Phase 3
595
Roma, Orbassano, Vicenza, Arezzo, Catania, Milan, Naples, Pavia
2019-07-24
Active, closed
Exelixis
Phase 3
855
Meldola, Faenza, Arezzo, Modena, Padova, Pavia, Perugia, Terni
2019-06-25
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
2,000
Acquaviva delle Fonti, Arezzo, Brescia, Florence, Milan, Negrar, Pavia, Perugia
2019-06-24
Active, closed
Bristol-Myers Squibb
Phase 3
437
Brescia, Arezzo, Aviano (PN), Milan, Parma, Roma
2019-06-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,397
Chieti, Milan, Turin, Bolzano, Florence, Arezzo, Bari, Genova
2018-12-24
Active, closed
AstraZeneca
Phase 3
724
Arezzo, Brescia, Milan, Pisa
2018-11-30
Active, closed
National Register of Actionable Mutations
NCT05918666Solid Tumours in Advanced Stages
Federation of Italian Cooperative Oncology Groups
Observational
2,098
Ancona, Arezzo, Avellino, Aviano, Bari, Bergamo, Brindisi, Catania
2018-10-27
Active, closed
AstraZeneca
Phase 3
1,246
Arezzo, Milan, Naples, Orbassano, Parma, Pavia, Roma, Terni
2018-09-27
Active, closed
Gilead Sciences
Phase 2
502
Arezzo, Aviano, Cremona, Genoa, Meldola, Milan, Novara, Padova
2018-08-13
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Alessandria, Arezzo, Aviano, Bergamo, Brescia, Cremona, Florence, Genova
2018-03-23
Active, closed
Savolitinib vs. Sunitinib in MET-driven PRCC.
NCT03091192Carcinoma, Carcinoma, Renal Cell, Kidney Neoplasms, Urologic Neoplasms
DrugsSavolitinib·Sunitinib
AstraZeneca
Phase 3
60
Arezzo, Meldola, Milan, Modena, Orbassano, Pavia, Roma
2017-07-25
Active, closed
Bristol-Myers Squibb
Phase 3
1,314
Arezzo, Faenza, Forlì, Grosseto, Milan, Naples
2017-03-24
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Faenza (RA), Arezzo, Candiolo, Cremona, Forlì, Roma, Toscana, Trento
2016-12-22
Active, closed
Eisai Inc.
Phase 3
1,069
Faenza, Arezzo, Bologna, Genova, Lecce, Meldola, Milan, Modena
2016-10-13
Active, closed
AstraZeneca
Phase 3
1,126
Arezzo, Meldola, Milan, Naples, Orbassano, Pavia, Roma, San Giovanni Rotondo
2015-11-02
Rows per page Showing 1–59 of 59
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-italy/city/arezzo

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 59 of those studies with a site in Arezzo.

How many clinical trials are recruiting in Arezzo?

22 of the 59 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 3 have not yet opened recruitment, 32 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Arezzo), 59 studies
PhaseStudiesRecruitingShare
Phase 338864.4%
Observational8713.6%
Not applicable7611.9%
Phase 2416.8%
Phase 4203.4%

Most active sponsors

Lead sponsors with the most studies (Arezzo)
Lead sponsorStudiesRecruiting
AstraZeneca92
Merck Sharp & Dohme LLC83
Janssen Research & Development, LLC61
Bristol-Myers Squibb20
Exelixis20
Pfizer20
University Hospital of Ferrara22
Almirall, S.A.10
ASST Ovest Milanese11
Astellas Pharma Global Development, Inc.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.